YC Startup Tracker
YC Startup Tracker
PublicTracking the latest YC Startups
Klaimee raises $5.5M to insure autonomous AI agents
Wednesday, Jul 22, 2026
Klaimee’s seed round marks a concrete step toward solving the emerging liability gap for autonomous AI agents, as traditional insurance policies fail to cover system-initiated errors.
The funding signals investor confidence in a new risk category and positions Klaimee as a potential gatekeeper for enterprise AI deployment.
Readers should watch how this model shifts accountability from users to insurers and whether it accelerates adoption of independent AI workflows.
Tracking: Y Combinator
Geography: Mountain View, San Francisco, Silicon Valley, United States
1. Klaimee raises $5.5m seed to insure autonomous AI agents
Klaimee, a Y Combinator-backed InsurTech, has secured $5. 5 million in seed funding to provide insurance-backed performance warranties for autonomous AI agents.
The round was led by FundersClub’s Alexander Mittal, with participation from Y Combinator and other investors.
The company addresses a new risk: who bears the cost when an AI agent makes a mistake, since traditional insurance policies are ill-suited for autonomous systems. Klaimee audits an agent’s performance and backs it with AI-specific liability coverage.
This funding reflects growing demand for insurance tailored to AI agents that act independently in enterprise workflows. The seed round positions Klaimee to certify and insure AI agents, helping businesses manage deployment risks.
Key facts:
- Klaimee raised $5.5 million in seed funding.
- The round was led by FundersClub’s Alexander Mittal.
- Investors include Y Combinator, ex/ante, Pioneer Fund, others.
- Klaimee provides insurance-backed performance warranties for AI agents.
- The company audits and insures autonomous AI agents.
Why it matters: Traditional insurance doesn't cover autonomous AI mistakes, creating a gap that Klaimee fills. This could reduce barriers for enterprises deploying AI agents, benefiting startups and large adopters.
Incumbent insurers may need to develop similar products or partner with specialists.
